Polatuzumab Vedotin Plus R-CHOP Being Explored in DLBCL Trial
Christopher R. Flowers, MD, MS, shares insights about the POLARIX trial in diffuse large B-cell lymphoma.
Source: OncLive
* Five Most Promising Investment Trends to Capitalize On in 2021
* Improving Your Security Online: 4 Simple Steps




